Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease
With his new study, George Goshua, MD, MSc, assistant professor of medicine (hematology), hopes to make clear that we cannot continue to ignore the importance
Source: yale.edu